Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aisling Capital IV
New York, New York, United States
- Ownership
- Private
- Employees
- ~13
- Development stage
- Other
01
Overview
Aisling Capital IV is a healthcare-focused venture capital fund, investing in companies developing and commercializing innovative drugs, devices, and healthcare technologies, with successful prior funds showing realized returns ranging from 1.39x to 1.88x and IRRs up to 25.3%. Clinical results vary per portfolio, not at the fund level.
- Therapeutic areas
- OncologyPulmonologyOtherRare Diseases
- Modalities
- Small moleculeMonoclonal antibodyGene therapyProteinBiologic
- Industry
- Investors
02
Partnerships
Portfolio companies partnering with major pharmas; Aisling itself partners with co-investors
Beyond the preview
Go deeper on Aisling Capital IV.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aisling Capital IV.